True to form, James Watson didn't mince words at a recent lecture at the Salk Institute for Biological Studies, where he said that the majority of cancer research is "irrelevant" and got into a verbal tussle with fellow Nobelist Roger Tsien.

The San Diego Union-Tribune reports that Watson, in a talk about the role of oxidants in cancer and diabetes, questioned the utility of sequencing cancer genomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Defending Open Access

Money and the Prize

Gathering the Data

A Year On

The Missing Drugs

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.